Sökning: onr:"swepub:oai:lup.lub.lu.se:9c505d7f-574b-4eac-8e27-5bfbd640f036" >
Characterization of...
Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals
-
- Dominguez, Mev (författare)
- Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
-
da Silva, Felipe Carneiro (författare)
-
Monteiro dos Santos, Erika Maria (författare)
-
visa fler...
-
Lisboa, Bianca Garcia (författare)
-
de Oliveira, Ligia Petrolini (författare)
-
Ferreira, Fabio de Oliveira (författare)
-
Gomy, Israel (författare)
-
Nakagawa, Wilson Toshihiko (författare)
-
Aguiar Junior, Samuel (författare)
-
Redal, Mariana (författare)
-
Vaccaro, Carlos (författare)
-
Della Valle, Adriana (författare)
-
Sarroca, Carlos (författare)
-
Carraro, Dirce Maria (författare)
-
Rossi, Benedito Mauro (författare)
-
visa färre...
-
(creator_code:org_t)
- 2011-06-17
- 2011
- Engelska.
-
Ingår i: Familial Cancer. - : Springer Science and Business Media LLC. - 1389-9600 .- 1573-7292. ; 10:4, s. 641-647
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Lynch syndrome (LS) is an autosomal dominant syndrome that predisposes individuals to development of cancers early in life. These cancers are mainly the following: colorectal, endometrial, ovarian, small intestine, stomach and urinary tract cancers. LS is caused by germline mutations in DNA mismatch repair genes (MMR), mostly MLH1 and MSH2, which are responsible for more than 85% of known germline mutations. To search for germline mutations in MLH1 and MSH2 genes in 123 unrelated South American suspected LS patients (Bethesda or Amsterdam Criteria) DNA was obtained from peripheral blood, and PCR was performed followed by direct sequencing in both directions of all exons and intron-exon junctions regions of the MLH1 and MSH2 genes. MLH1 or MSH2 pathogenic mutations were found in 28.45% (34/123) of the individuals, where 25/57 (43.85%) fulfilled Amsterdam I, II and 9/66 (13.63%) the Bethesda criteria. The mutations found in both genes were as follows: nonsense (35.3%), frameshift (26.47%), splicing (23.52%), and missense (9%). Thirteen alterations (35.14%) were described for the first time. The data reported in this study add new information about MLH1 and MSH2 gene mutations and contribute to better characterize LS in Brazil, Uruguay and Argentina. The high rate of novel mutations demonstrates the importance of defining MLH1 and MSH2 mutations in distinct LS populations.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Lynch syndrome
- MSH2
- MLH1
- MMR genes
- Mutation
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Dominguez, Mev
-
da Silva, Felipe ...
-
Monteiro dos San ...
-
Lisboa, Bianca G ...
-
de Oliveira, Lig ...
-
Ferreira, Fabio ...
-
visa fler...
-
Gomy, Israel
-
Nakagawa, Wilson ...
-
Aguiar Junior, S ...
-
Redal, Mariana
-
Vaccaro, Carlos
-
Della Valle, Adr ...
-
Sarroca, Carlos
-
Carraro, Dirce M ...
-
Rossi, Benedito ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Familial Cancer
- Av lärosätet
-
Lunds universitet